Shukra Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 41.094 million compared to INR 40.429 million a year ago. Net loss was INR 2.509 million compared to INR 4.035 million a year ago. For the full year, total revenue was INR 115.523 million compared to INR 118.557 million a year ago. Net income was INR 0.338 million compared to INR 0.356 million a year ago. Basic earnings per share from continuing operations was INR 0.22 compared to INR 0.23 a year ago.